Hub : Traits :

Tense / 'highly strung'

220 significantly associated models · 46 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	7715776	9571422	2	1	1.4e-07	4.8e-08	0.0291	84	RERE
2	1	173103273	175663031	2	1	1.1e-08	3.2e-09	1.0000	100	RABGAP1L
3	3	49615624	51077419	3	1	8.4e-08	1.1e-07	0.0507	86	CYB561D2
4	3	51616334	53015839	1	1	1.5e-07	6.5e-06	0.8440	100	WDR82
5	3	84317575	86808226	1	1	5.6e-09	7.3e-09	0.0164	83	CADM2
6	5	64115004	65711805	6	1	1.6e-09	1.1e-09	0.1430	94	CTC-534A2.2
7	6	147140769	148587096	1	1	2.9e-07	1.6e-06	0.1630	92	SAMD5
8	7	11553163	12967449	1	1	1.3e-07	2.9e-09	0.0023	74	TMEM106B
9	8	8092025	12966739	15	1	3.8e-13	5.7e-11	0.0063	83	AF131215.9
10	9	95502571	96913764	2	1	2.8e-08	2.9e-08	0.1260	92	RP11-165J3.6
11	16	30347731	31833122	8	1	4.2e-08	6.3e-08	0.3130	96	MYST1
12	17	34256906	35644076	1	1	3.0e-08	3.1e-04	0.5420	97	DHRS11
13	22	40946307	42614362	3	1	5.2e-08	3.9e-08	0.1570	93	L3MBTL2

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Bipolar Disorder (2018)	2.30	1	0	0.0	0.00	1.0e+00	WDR82
Bipolar Disorder or Schizophrenia	3.39	3	1	2.2	0.00	1.0e+00	L3MBTL2 RERE WDR82
Depressed Affect (Nagel 2018)	7.38	7	2	4.4	0.98	5.7e-05	L3MBTL2 MYST1 RABGAP1L RERE RP11-165J3.6 SAMD5 TMEM106B
Depression (Nagel 2018)	6.74	4	2	4.4	1.00	4.4e-03	CYB561D2 RERE RP11-165J3.6 TMEM106B
Intelligence (Savage-Jansen 2018)	2.45	2	1	2.2	0.00	1.0e+00	RABGAP1L WDR82
Neuroticism (Nagel 2018)	11.40	12	6	13.3	0.98	4.8e-08	AF131215.9 CADM2 CTC-534A2.2 CYB561D2 L3MBTL2 MYST1 RABGAP1L RERE RP11-165J3.6 SAMD5 TMEM106B WDR82
Schizophrenia (2018)	3.01	3	0	0.0	0.00	1.0e+00	L3MBTL2 RERE WDR82
Worry (Nagel 2018)	14.40	10	6	13.3	0.97	2.7e-06	CADM2 CTC-534A2.2 CYB561D2 L3MBTL2 MYST1 RABGAP1L RERE RP11-165J3.6 TMEM106B WDR82
Alzheimer’s Disease (including proxy)	2.77	1	0	0.0	0.00	1.0e+00	MYST1
Ulcerative Colitis (UC)	1.37	1	0	0.0	0.00	1.0e+00	CADM2
Major Depression (MDD)	4.32	1	0	0.0	0.00	1.0e+00	TMEM106B
Reaction Time	1.96	1	0	0.0	0.00	1.0e+00	RERE
Verbal and Numeric Reasoning (VNR)	2.61	1	0	0.0	0.00	1.0e+00	WDR82
Bipolar Disorder (2011)	3.71	1	0	0.0	0.00	1.0e+00	WDR82
Lupus	1.92	1	0	0.0	0.00	1.0e+00	AF131215.9
Neuroticism (2016)	8.28	3	1	2.2	0.00	1.0e+00	AF131215.9 L3MBTL2 WDR82
Schizophrenia (2014)	2.98	3	0	0.0	0.00	1.0e+00	L3MBTL2 RERE WDR82
Triglycerides	2.06	1	0	0.0	0.00	1.0e+00	MYST1
Blood Eosinophil Count	2.38	4	3	6.7	0.35	6.5e-01	CYB561D2 L3MBTL2 RERE WDR82
Blood Platelet Count	0.61	2	1	2.2	0.00	1.0e+00	CYB561D2 WDR82
Blood Red Count	1.83	4	4	8.9	-0.12	8.8e-01	CYB561D2 MYST1 RABGAP1L WDR82
Blood White Count	0.84	1	1	2.2	0.00	1.0e+00	RERE
Heel T-Score	3.45	3	2	4.4	0.00	1.0e+00	L3MBTL2 MYST1 RERE
BMI	3.16	6	2	4.4	-0.43	4.0e-01	CADM2 CYB561D2 MYST1 RABGAP1L TMEM106B WDR82
Height	1.52	5	5	11.1	0.68	2.0e-01	CYB561D2 RERE RP11-165J3.6 TMEM106B WDR82
Waist Hip Ratio (WHR)	2.32	2	2	4.4	0.00	1.0e+00	CYB561D2 WDR82
Systolic Blood Pressure	1.66	2	2	4.4	0.00	1.0e+00	CADM2 RERE
Smoking Status	3.92	3	2	4.4	0.00	1.0e+00	CADM2 RERE WDR82
Allergy or Eczema	4.13	2	2	4.4	0.00	1.0e+00	L3MBTL2 RERE
Cardiovascular Disease	1.88	2	1	2.2	0.00	1.0e+00	MYST1 RERE
Hypothyroidism (self reported)	2.06	1	0	0.0	0.00	1.0e+00	RERE
Respiratory disease	3.57	3	1	2.2	0.00	1.0e+00	L3MBTL2 RABGAP1L RERE
Lung FEV1/FVC ratio	0.95	1	0	0.0	0.00	1.0e+00	RERE
Lung FVC	2.16	2	2	4.4	0.00	1.0e+00	CYB561D2 MYST1
Neuroticism	9.32	11	5	11.1	0.99	1.7e-09	CADM2 CTC-534A2.2 CYB561D2 L3MBTL2 MYST1 RABGAP1L RERE RP11-165J3.6 SAMD5 TMEM106B WDR82
Chronotype (morning person)	3.30	3	1	2.2	0.00	1.0e+00	CYB561D2 DHRS11 SAMD5
Hair Pigment	0.15	1	1	2.2	0.00	1.0e+00	L3MBTL2
Tanning	0.62	2	1	2.2	0.00	1.0e+00	CADM2 WDR82
Hand grip strength (left)	1.41	1	0	0.0	0.00	1.0e+00	CADM2
Number of treatments/medications taken	3.93	3	0	0.0	0.00	1.0e+00	MYST1 RABGAP1L SAMD5
Sensitivity / hurt feelings	5.58	2	2	4.4	0.00	1.0e+00	AF131215.9 RP11-165J3.6
Frequency of depressed mood in last 2 weeks	7.42	5	0	0.0	0.99	9.2e-04	AF131215.9 RERE RP11-165J3.6 TMEM106B WDR82
Relative age of first facial hair	2.13	2	0	0.0	0.00	1.0e+00	CYB561D2 RABGAP1L
Systolic blood pressure, automated reading	2.51	2	2	4.4	0.00	1.0e+00	AF131215.9 RERE
Impedance of leg (right)	4.36	3	3	6.7	0.00	1.0e+00	AF131215.9 CADM2 CYB561D2
Leg fat-free mass (left)	2.05	3	2	4.4	0.00	1.0e+00	AF131215.9 CADM2 MYST1
Trunk fat percentage	2.49	3	2	4.4	0.00	1.0e+00	L3MBTL2 MYST1 RERE
Current tobacco smoking	2.37	1	0	0.0	0.00	1.0e+00	L3MBTL2
Fed-up feelings	4.81	2	1	2.2	0.00	1.0e+00	AF131215.9 DHRS11
Frequency of unenthusiasm / disinterest in last 2 weeks	4.81	3	0	0.0	0.00	1.0e+00	CYB561D2 RP11-165J3.6 TMEM106B
Taking other prescription medications	4.38	1	0	0.0	0.00	1.0e+00	L3MBTL2
Age when periods started (menarche)	2.23	2	0	0.0	0.00	1.0e+00	CYB561D2 WDR82
Heel bone mineral density (BMD) T-score, automated (left)	5.40	3	3	6.7	0.00	1.0e+00	AF131215.9 L3MBTL2 RERE
High blood pressure	2.70	3	1	2.2	0.00	1.0e+00	AF131215.9 MYST1 RERE
Hayfever, allergic rhinitis or eczema	3.79	2	1	2.2	0.00	1.0e+00	L3MBTL2 RERE
Medication: Levothyroxine sodium	2.33	2	0	0.0	0.00	1.0e+00	AF131215.9 RERE
Sitting height	0.77	1	0	0.0	0.00	1.0e+00	WDR82
Body mass index (BMI)	4.11	5	3	6.7	-0.67	2.1e-01	AF131215.9 CADM2 MYST1 RERE TMEM106B
Impedance of leg (left)	4.39	4	3	6.7	0.62	3.8e-01	AF131215.9 CADM2 CYB561D2 WDR82
Leg predicted mass (left)	2.02	3	2	4.4	0.00	1.0e+00	AF131215.9 CADM2 MYST1
Trunk fat mass	2.45	4	1	2.2	-0.46	5.4e-01	CADM2 L3MBTL2 MYST1 RERE
Waist circumference	2.93	2	2	4.4	0.00	1.0e+00	CADM2 MYST1
Number of incorrect matches in round	2.61	1	0	0.0	0.00	1.0e+00	MYST1
Past tobacco smoking	4.13	2	1	2.2	0.00	1.0e+00	CADM2 WDR82
Alcohol usually taken with meals	1.72	1	0	0.0	0.00	1.0e+00	RABGAP1L
Nervous feelings	11.89	6	4	8.9	0.98	8.4e-04	AF131215.9 CADM2 CYB561D2 L3MBTL2 MYST1 WDR82
Frequency of tenseness / restlessness in last 2 weeks	6.74	3	0	0.0	0.00	1.0e+00	RP11-165J3.6 TMEM106B WDR82
Forced vital capacity (FVC)	1.52	1	1	2.2	0.00	1.0e+00	MYST1
Heel bone mineral density (BMD) T-score, automated (right)	5.80	3	2	4.4	0.00	1.0e+00	AF131215.9 L3MBTL2 RERE
Ever unenthusiastic/disinterested for a whole week	3.28	1	0	0.0	0.00	1.0e+00	CYB561D2
Financial difficulties in last 2 years	1.78	1	0	0.0	0.00	1.0e+00	TMEM106B
Allergy	3.93	3	1	2.2	0.00	1.0e+00	CYB561D2 L3MBTL2 RERE
Pain all over the body in last month	2.92	1	0	0.0	0.00	1.0e+00	SAMD5
Illnesses of siblings	2.77	1	0	0.0	0.00	1.0e+00	MYST1
Neuroticism score	14.03	11	4	8.9	0.97	4.5e-07	AF131215.9 CADM2 CYB561D2 L3MBTL2 MYST1 RABGAP1L RERE RP11-165J3.6 SAMD5 TMEM106B WDR82
Weight	2.62	4	3	6.7	0.13	8.7e-01	AF131215.9 CADM2 MYST1 RABGAP1L
Impedance of arm (right)	4.52	6	3	6.7	0.77	7.0e-02	AF131215.9 CADM2 CYB561D2 L3MBTL2 TMEM106B WDR82
Arm fat percentage (right)	2.86	4	1	2.2	0.33	6.7e-01	AF131215.9 CADM2 MYST1 RERE
Trunk fat-free mass	1.76	3	1	2.2	0.00	1.0e+00	AF131215.9 CADM2 RABGAP1L
Hip circumference	2.99	4	2	4.4	0.17	8.3e-01	AF131215.9 CADM2 MYST1 RABGAP1L
Worrier / anxious feelings	12.02	8	4	8.9	0.97	4.4e-05	AF131215.9 CADM2 CYB561D2 L3MBTL2 MYST1 RP11-165J3.6 TMEM106B WDR82
Frequency of tiredness / lethargy in last 2 weeks	6.39	3	1	2.2	0.00	1.0e+00	L3MBTL2 RP11-165J3.6 TMEM106B
Forced expiratory volume in 1-second (FEV1)	1.95	1	1	2.2	0.00	1.0e+00	MYST1
Asthma	3.13	2	1	2.2	0.00	1.0e+00	L3MBTL2 RERE
Depression (self-reported)	5.84	2	0	0.0	0.00	1.0e+00	RERE TMEM106B
Forced expiratory volume in 1-second (FEV1), Best measure	2.31	1	1	2.2	0.00	1.0e+00	MYST1
Impedance of arm (left)	4.29	6	4	8.9	0.79	6.4e-02	AF131215.9 CADM2 CYB561D2 L3MBTL2 TMEM106B WDR82
Arm fat mass (right)	3.16	4	3	6.7	-0.21	7.9e-01	AF131215.9 CADM2 MYST1 RERE
Trunk predicted mass	1.73	3	1	2.2	0.00	1.0e+00	AF131215.9 CADM2 RABGAP1L
Standing height	1.47	5	3	6.7	0.67	2.1e-01	CYB561D2 RERE RP11-165J3.6 TMEM106B WDR82
Seen doctor (GP) for nerves, anxiety, tension or depression	8.31	5	2	4.4	0.98	3.1e-03	CTC-534A2.2 RP11-165J3.6 SAMD5 TMEM106B WDR82
Hair/balding pattern: Pattern 4	1.54	1	0	0.0	0.00	1.0e+00	RERE
Peak expiratory flow (PEF)	1.69	1	0	0.0	0.00	1.0e+00	AF131215.9
Medication: Paracetamol	3.34	1	1	2.2	0.00	1.0e+00	RABGAP1L
Headache pain in last month	2.43	1	0	0.0	0.00	1.0e+00	RABGAP1L
Hypothyroidism/myxoedema (self-reported)	2.75	2	1	2.2	0.00	1.0e+00	AF131215.9 RERE
High blood pressure (siblings)	2.93	2	0	0.0	0.00	1.0e+00	MYST1 TMEM106B
Forced vital capacity (FVC), Best measure	1.75	1	1	2.2	0.00	1.0e+00	MYST1
Body fat percentage	2.82	3	2	4.4	0.00	1.0e+00	L3MBTL2 MYST1 RERE
Leg fat percentage (right)	3.22	3	2	4.4	0.00	1.0e+00	AF131215.9 MYST1 RERE
Arm fat-free mass (right)	2.34	3	3	6.7	0.00	1.0e+00	AF131215.9 CADM2 MYST1
Comparative body size at age 10	6.21	7	5	11.1	-0.79	3.4e-02	AF131215.9 CADM2 CYB561D2 L3MBTL2 MYST1 RERE RP11-165J3.6
Worry too long after embarrassment	4.51	1	1	2.2	0.00	1.0e+00	AF131215.9
Seen a psychiatrist for nerves, anxiety, tension or depression	7.01	5	0	0.0	1.00	7.0e-05	CTC-534A2.2 L3MBTL2 SAMD5 TMEM106B WDR82
Wheeze or whistling in the chest in last year	4.41	2	0	0.0	0.00	1.0e+00	RERE RP11-165J3.6
Number of children fathered	2.25	1	0	0.0	0.00	1.0e+00	CADM2
Age at first live birth	1.84	1	0	0.0	0.00	1.0e+00	AF131215.9
Qualifications: College or University degree	1.18	1	0	0.0	0.00	1.0e+00	RABGAP1L
Medication for pain relief, constipation, heartburn	4.76	2	1	2.2	0.00	1.0e+00	RABGAP1L RP11-165J3.6
Mean time to correctly identify matches	1.89	1	0	0.0	0.00	1.0e+00	RERE
Whole body fat mass	2.82	4	1	2.2	0.41	5.9e-01	AF131215.9 CADM2 MYST1 RERE
Leg fat mass (right)	3.59	4	3	6.7	0.16	8.4e-01	AF131215.9 CADM2 MYST1 RERE
Arm predicted mass (right)	2.32	3	3	6.7	0.00	1.0e+00	AF131215.9 CADM2 MYST1
Pulse rate, automated reading	1.48	3	0	0.0	0.00	1.0e+00	CYB561D2 MYST1 RABGAP1L
Alcohol intake frequency.	2.66	2	1	2.2	0.00	1.0e+00	CADM2 L3MBTL2
Comparative height size at age 10	0.92	2	0	0.0	0.00	1.0e+00	RERE WDR82
Number of full sisters	3.02	1	0	0.0	0.00	1.0e+00	CADM2
Suffer from 'nerves'	9.42	5	2	4.4	0.61	2.7e-01	AF131215.9 CADM2 MYST1 RERE WDR82
Overall health rating	4.14	3	0	0.0	0.00	1.0e+00	CYB561D2 MYST1 RP11-165J3.6
Age at last live birth	2.44	1	0	0.0	0.00	1.0e+00	CADM2
Knee pain experienced in last month	2.87	1	0	0.0	0.00	1.0e+00	RABGAP1L
Hypertension (Self-reported)	2.78	3	1	2.2	0.00	1.0e+00	AF131215.9 MYST1 RERE
Smoking status: Previous	3.48	1	1	2.2	0.00	1.0e+00	CADM2
Forced expiratory volume in 1-second (FEV1), predicted	1.48	1	0	0.0	0.00	1.0e+00	CYB561D2
Whole body fat-free mass	1.93	3	2	4.4	0.00	1.0e+00	AF131215.9 CADM2 MYST1
Leg fat-free mass (right)	1.96	3	2	4.4	0.00	1.0e+00	AF131215.9 CADM2 MYST1
Arm fat percentage (left)	2.96	3	2	4.4	0.00	1.0e+00	AF131215.9 MYST1 RERE
Average weekly red wine intake	2.39	1	0	0.0	0.00	1.0e+00	CADM2
Mood swings	8.92	4	3	6.7	0.99	8.7e-03	AF131215.9 L3MBTL2 RP11-165J3.6 TMEM106B
Loneliness, isolation	4.77	2	0	0.0	0.00	1.0e+00	RERE TMEM106B
Long-standing illness, disability or infirmity	2.66	1	0	0.0	0.00	1.0e+00	TMEM106B
Mouth/teeth dental problems: Mouth ulcers	1.58	1	0	0.0	0.00	1.0e+00	CADM2
Medication for cholesterol	2.00	1	0	0.0	0.00	1.0e+00	MYST1
Asthma (self-reported)	2.93	1	1	2.2	0.00	1.0e+00	RERE
Forced expiratory volume in 1-second (FEV1), predicted percentage	2.54	1	1	2.2	0.00	1.0e+00	MYST1
Whole body water mass	1.93	3	2	4.4	0.00	1.0e+00	AF131215.9 CADM2 MYST1
Leg predicted mass (right)	1.96	3	2	4.4	0.00	1.0e+00	AF131215.9 CADM2 MYST1
Arm fat mass (left)	3.27	4	3	6.7	-0.11	8.9e-01	AF131215.9 CADM2 MYST1 RERE
Number of self-reported non-cancer illnesses	3.73	2	0	0.0	0.00	1.0e+00	L3MBTL2 TMEM106B
Miserableness	8.10	3	3	6.7	0.00	1.0e+00	AF131215.9 RP11-165J3.6 TMEM106B
Guilty feelings	4.44	1	1	2.2	0.00	1.0e+00	AF131215.9
Medication: Blood pressure	2.21	2	0	0.0	0.00	1.0e+00	AF131215.9 MYST1
High cholesterol (Self-reported)	1.79	1	0	0.0	0.00	1.0e+00	MYST1
Medication: Bendroflumethiazide	2.80	1	1	2.2	0.00	1.0e+00	AF131215.9
Medication: Paracetamol	2.71	1	1	2.2	0.00	1.0e+00	RABGAP1L
Ever smoked	3.32	2	1	2.2	0.00	1.0e+00	CADM2 WDR82
Basal metabolic rate	2.10	4	3	6.7	-0.25	7.5e-01	AF131215.9 CADM2 MYST1 RABGAP1L
Leg fat percentage (left)	3.15	4	2	4.4	0.60	4.0e-01	AF131215.9 CADM2 MYST1 RERE
Arm fat-free mass (left)	2.29	4	3	6.7	-0.14	8.6e-01	AF131215.9 CADM2 MYST1 RABGAP1L
Number of operations (self-reported)	3.21	1	0	0.0	0.00	1.0e+00	SAMD5
Average weekly beer plus cider intake	2.60	1	0	0.0	0.00	1.0e+00	AF131215.9
Irritability	8.76	5	2	4.4	0.99	1.8e-03	AF131215.9 L3MBTL2 MYST1 SAMD5 TMEM106B
Risk taking	5.03	2	1	2.2	0.00	1.0e+00	AF131215.9 CADM2
Diastolic blood pressure, automated reading	3.33	3	2	4.4	0.00	1.0e+00	AF131215.9 MYST1 RERE
Vascular/heart problems diagnosed by doctor	2.58	3	1	2.2	0.00	1.0e+00	AF131215.9 MYST1 RERE
Cholesterol lowering medication	1.46	1	0	0.0	0.00	1.0e+00	MYST1
Pain experienced in last month	2.99	3	0	0.0	0.00	1.0e+00	MYST1 RABGAP1L RP11-165J3.6
Impedance of whole body	4.97	6	3	6.7	0.83	3.9e-02	AF131215.9 CADM2 CYB561D2 L3MBTL2 TMEM106B WDR82
Leg fat mass (left)	3.50	4	3	6.7	0.12	8.8e-01	AF131215.9 CADM2 MYST1 RERE
Arm predicted mass (left)	2.43	4	3	6.7	-0.23	7.7e-01	AF131215.9 CADM2 MYST1 RABGAP1L

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	6	0.172	1.7
GTEx	Adipose Visceral Omentum	4	0.196	1.8
GTEx	Adrenal Gland	4	0.275	1.7
GTEx	Artery Aorta	6	0.202	1.7
GTEx	Artery Coronary	1	0.085	1.8
GTEx	Artery Tibial	7	0.186	1.7
GTEx	Brain Caudate basal ganglia	0	0.000	1.8
GTEx	Brain Cerebellar Hemisphere	2	0.134	1.8
GTEx	Brain Cerebellum	1	0.050	1.7
GTEx	Brain Cortex	1	0.097	1.8
GTEx	Brain Frontal Cortex BA9	1	0.108	1.8
GTEx	Brain Hippocampus	0	0.000	1.9
GTEx	Brain Hypothalamus	0	0.000	1.6
GTEx	Brain Nucleus accumbens basal ganglia	0	0.000	1.6
GTEx	Brain Putamen basal ganglia	2	0.321	1.7
GTEx	Breast Mammary Tissue	4	0.203	1.8
GTEx	Breast Mammary Tissue (Male)	1	0.084	1.7
GTEx	Breast Mammary Tissue (Female)	3	0.182	1.7
GTEx	Cells EBV-transformed lymphocytes	2	0.141	1.8
GTEx	Cells Transformed fibroblasts	3	0.071	1.6
GTEx	Colon Sigmoid	4	0.274	1.7
GTEx	Colon Transverse	6	0.291	1.8
GTEx	Esophagus Gastroesophageal Junction	3	0.208	1.8
GTEx	Esophagus Mucosa	8	0.241	1.7
GTEx	Esophagus Muscularis	6	0.186	1.8
GTEx	Heart Atrial Appendage	3	0.190	1.8
GTEx	Heart Left Ventricle	4	0.261	1.8
GTEx	Liver	0	0.000	1.7
GTEx	Lung	8	0.278	1.8
GTEx	Muscle Skeletal	3	0.104	1.6
GTEx	Nerve Tibial	7	0.162	1.7
GTEx	Ovary	0	0.000	1.9
GTEx	Pancreas	3	0.184	1.7
GTEx	Pituitary	3	0.269	1.9
GTEx	Prostate	2	0.240	1.7
GTEx	Skin Not Sun Exposed Suprapubic	6	0.244	1.8
GTEx	Skin Sun Exposed Lower leg	8	0.220	1.7
GTEx	Small Intestine Terminal Ileum	1	0.217	2.1
GTEx	Spleen	2	0.142	1.9
GTEx	Stomach	3	0.206	1.8
GTEx	Testis	6	0.190	1.8
GTEx	Thyroid	8	0.200	1.7
GTEx	Uterus	4	0.705	1.8
GTEx	Vagina	1	0.157	1.7
GTEx	Whole Blood	1	0.050	1.7
METSIM	Adipose	7	0.152	1.6
NTR	Blood	4	0.167	1.6
ROSMAP	Brain Pre-frontal Cortex	16	0.364	1.8
YFS	Blood	5	0.108	1.5
CommonMind	Brain Pre-frontal Cortex	3	0.056	1.6
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	2	0.121	1.6
The Cancer Genome Atlas	Breast Invasive Carcinoma	3	0.068	1.5
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	0	0.000	1.6
The Cancer Genome Atlas	Colon Adenocarcinoma	1	0.048	1.6
The Cancer Genome Atlas	Esophageal Carcinoma	2	0.292	1.9
The Cancer Genome Atlas	Glioblastoma Multiforme	0	0.000	1.6
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	4	0.147	1.6
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	1	0.024	1.5
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	2	0.098	1.6
The Cancer Genome Atlas	Brain Lower Grade Glioma	3	0.070	1.5
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	3	0.271	1.6
The Cancer Genome Atlas	Lung Adenocarcinoma	2	0.068	1.5
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	2	0.080	1.6
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	2	0.126	1.5
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	0	0.000	1.6
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	3	0.226	1.7
The Cancer Genome Atlas	Prostate Adenocarcinoma	1	0.022	1.6
The Cancer Genome Atlas	Rectum Adenocarcinoma	0	0.000	1.5
The Cancer Genome Atlas	Soft Tissue Sarcoma	0	0.000	1.5
The Cancer Genome Atlas	Skin Cutaneous Melanoma	0	0.000	1.5
The Cancer Genome Atlas	Stomach Adenocarcinoma	1	0.059	1.6
The Cancer Genome Atlas	Testicular Germ Cell Tumors	2	0.156	1.7
The Cancer Genome Atlas	Thyroid Carcinoma	3	0.058	1.5
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	0	0.000	1.5